Fang M - Search Results

1

Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis.

Fang M, Yao M, Yang J, Zheng WJ, Wang L, Yao DF. Fang M, et al. World J Gastrointest Oncol. 2020 Jan 15;12(1):66-76. doi: 10.4251/wjgo.v12.i1.66. World J Gastrointest Oncol. 2020. PMID: 31966914 Free PMC article.

2

Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes.

Zheng WJ, Yao M, Fang M, Wang L, Dong ZZ, Yao DF. Zheng WJ, et al. Among authors: fang m. World J Gastroenterol. 2018 Aug 28;24(32):3650-3662. doi: 10.3748/wjg.v24.i32.3650. World J Gastroenterol. 2018. PMID: 30166860 Free PMC article.

3

[Quantitative detection and clinical value of CD44 in patients with nonalcoholic fatty liver disease].

Fang M, Yao M, Yang JL, Wang L, Sun JY, Wu MN, Yao DF, Tai BJ. Fang M, et al. Zhonghua Gan Zang Bing Za Zhi. 2019 Dec 20;27(12):994-1000. doi: 10.3760/cma.j.issn.1007-3418.2019.12.012. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 31941262 Chinese.

4

Advances in the study of oncofetal antigen glypican-3 expression in HBV-related hepatocellular carcinoma.

Yao M, Wang L, Fang M, Zheng W, Dong Z, Yao D. Yao M, et al. Among authors: fang m. Biosci Trends. 2016 Nov 15;10(5):337-343. doi: 10.5582/bst.2016.01176. Epub 2016 Oct 29. Biosci Trends. 2016. PMID: 27795482 Free article. Review.

5

Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition.

Dong Z, Chen J, Yang X, Zheng W, Wang L, Fang M, Wu M, Yao M, Yao D. Dong Z, et al. Among authors: fang m. Oncotarget. 2018 Jan 9;9(16):12705-12717. doi: 10.18632/oncotarget.24061. eCollection 2018 Feb 27. Oncotarget. 2018. PMID: 29560103 Free PMC article.

6

Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.

Wang L, Yao M, Fang M, Zheng WJ, Dong ZZ, Pan LH, Zhang HJ, Yao DF. Wang L, et al. Among authors: fang m. Hepatobiliary Pancreat Dis Int. 2018 Jun;17(3):227-232. doi: 10.1016/j.hbpd.2018.03.005. Epub 2018 Mar 13. Hepatobiliary Pancreat Dis Int. 2018. PMID: 29709351

7

Role of secretory clusterin in hepatocarcinogenesis.

Yao M, Fang M, Zheng W, Dong Z, Yao D. Yao M, et al. Among authors: fang m. Transl Gastroenterol Hepatol. 2018 Aug 1;3:48. doi: 10.21037/tgh.2018.07.13. eCollection 2018. Transl Gastroenterol Hepatol. 2018. PMID: 30221206 Free PMC article. Review.

8

Insulin-like Growth Factor I Receptor: A Novel Target for Hepatocellular Carcinoma Gene Therapy.

Wang L, Yao M, Zheng W, Fang M, Wu M, Sun J, Dong Z, Yao D. Wang L, et al. Among authors: fang m. Mini Rev Med Chem. 2019;19(4):272-280. doi: 10.2174/1389557518666181025151608. Mini Rev Med Chem. 2019. PMID: 30360707 Review.

9

High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma.

Zheng W, Yang J, Dong Z, Wang L, Fang M, Wu W, Yao D, Yao M. Zheng W, et al. Among authors: fang m. Cancer Manag Res. 2018 Nov 20;10:5979-5989. doi: 10.2147/CMAR.S181742. eCollection 2018. Cancer Manag Res. 2018. PMID: 30538547 Free PMC article.

10

Food for thought on hepatocellular carcinoma.

Fang M, Yao M, Wang L, Yao DF. Fang M, et al. Hepatobiliary Pancreat Dis Int. 2019 Oct;18(5):493-494. doi: 10.1016/j.hbpd.2019.04.010. Epub 2019 Apr 24. Hepatobiliary Pancreat Dis Int. 2019. PMID: 31047806 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,327 results

Search Page

Filters